Home > Healthcare & Medical Devices > Sleep Disorder Market
Industry trends
Sleep Disorder Market size exceeded USD 13.3 billion in 2020 and is estimated to witness 6.6% CAGR from 2021 to 2027. Surging prevalence of sleep disorders such as sleep apnea, narcolepsy and insomnia across the globe is likely to drive the industry growth.
Get more details on this report - Request Free Sample PDF
The availability of effective diagnosis and treatment of the disorder is further likely to fuel the market progression. Moreover, COVID-19 impact on the industry is observed to be significant during the COVID-19 pandemic as the instances of sleep disorders saw a surge. For instance, a study from Lancet stated that, sleep problems became common during the COVID-19 pandemic due to higher levels of psychological distress. However, despite the cases being high, the market was hampered by lockdowns, disruption in supply chain, and postponing of non-emergency cases. The industry is expected to bolster in the coming years as situations are heading to new normal.
Product innovation by companies and technological advancements in devices
Technological advancements such as development of advanced sleep diagnostic and therapeutic devices will escalate the sleep disorder market growth. For instance, in February 2021, The US Food and Drug Administration has authorised the sale of eXciteOSA, a novel prescription-only device designed to reduce snoring and moderate obstructive sleep apnea. The device works by administering electrical muscle stimulation through a mouthpiece that rests around the tongue, which allows for optimal ventilation. Additionally, it is s the first marketed device designed to be used while awake.
| Report Coverage | Details |
|---|---|
| Base Year: | 2020 |
| Market Size in 2020: | 13.3 Billion (USD) |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 6.6% |
| 2027 Value Projection: | 20.6 Billion (USD) |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 246 |
| Tables, Charts & Figures: | 220 |
| Segments covered: | Disorder type, By Product and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Get more details on this report - Request Free Sample PDF
Surging cases of sleep apnea
Get more details on this report - Request Free Sample PDF
The sleep apnea segment is poised to register 6.8% gains through 2027. In person suffering with sleep apnea, the breathing stops repeatedly for 10 seconds or more during the sleep. A report from American sleep Apnea Association stated that, around 22 million Americans are currently suffering from sleep apnea. This has created demand for sleep apnea devices such as PAP devices, masks, and sleep ventilators. Furthermore, the increasing trend of oral appliances and home sleep care for the management of sleep apnea will spur the market revenue.
Surging demand for sleep diagnostic devices will favor the sleep disorder market space
The diagnostics segment accounted for more than USD 814.2 million revenue in 2020 owing to growing demand for sleep disorder diagnosis. Additionally, development of new diagnostic devices is propelling the industry statistics. For instance, in December 2020, a Belgian startup ‘Sunrise’, in collaboration with institutions such as National Heart and Lung Institute and Imperial college the company launched a chin sensor to diagnose sleep apnea. It is world’s first sleep test device that detects sleep disorders using a device that sits on patient’s chin.
Increasing awareness programs regarding sleep disorders in North America
Get more details on this report - Request Free Sample PDF
North America sleep disorder market captured above 44% of the revenue share in 2020 and is projected to grow substantially through 2027 driven by the increasing funding on awareness program about sleep disorder. Moreover, increasing expenditure on healthcare, presence of well-established healthcare sector will augment the industry development. The increasing number of new products launches as well as the high penetration of key players in the region is boosting the market demand.
Presence of numerous companies will enhance the industry expansion
Some of the prominent sleep disorder market players include, Astellas Pharma Inc, Cadwell Laboratories Inc., Cardinal Health, Compumedics Limited, Eisai Co Ltd, Evotec AG, Ferring International Center SA, GlaxoSmithKline plc, Heptares Therapeutics Ltd, Koninklijke Philips N.V., Natus Medical Incorporated, ResMed Inc., Somnetics International, Inc., Takeda Pharmaceutical Company Limited, Teleflex Inc., and Teva Pharmaceutical Industries Ltd., among others. Companies are implementing various growth strategies to sustain market competition.
This market research report on sleep disorder includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:
Market, By Disorder Type, 2016-2027 (USD Million)
- Sleep apnea
- Obstructive sleep apnea
- Central sleep apnea
- Complex sleep apnea
- Insomnia
- Restless legs syndrome (RLS)
- Narcolepsy
- Others
Market, By Product, 2016-2027 (USD Million)
- Diagnostics
- Actigraphy systems
- Polysomnography (PSG) device
- Respiratory polygraph
- Sleep screening devices
- Home sleep tests
- Others
- Therapeutics
- Cognitive behavioral therapy
- Therapeutic devices
- Airway clearance system
- Adaptive servo-ventilation (ASV)
- Positive airway pressure (PAP) devices
- Oral appliances
- Oxygen devices
- Others
- Medication therapy
- Benzodiazepines
- Dual orexin receptor antagonists
- Melatonin receptor agonists
- Antidepressants
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- New Zealand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
Frequently Asked Questions (FAQ) :